title: Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report.
abstract: In the recent years, anti-angiogenic medications have successfully treated other diseases associated with choroidal neovascularization. The anti-angiogenic therapy alone or combined with LASER and/or steroids has been effective in controlling ocular neovascularization, not only restricted to the treatment of typical membranes due to macular degeneration in the wet form. The discovery and subsequent use of these drugs has revolutionized medicine and ophthalmology. This report illustrates an example of successful treatment in a challenging pathology where it was found important visual and anatomical response after the use of ranibizumab.
authors: Retina Departament, Hospital de Olhos Santa Luzia, Recife, PE, Brazil. alexandreventura@hotmail.com
authors: Alexandre Augusto Cabral de Mello
authors: AA
authors: Ventura
authors: Lorna Winifred
authors: LW
authors: Grant
authors: Hajir
authors: H
authors: Dadgostar
authors: Hilel
authors: H
authors: Lewis
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008268:Macular Degeneration / Q000188:drug therapy*; D008875:Middle Aged; D000069579:Ranibizumab; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab